XML 24 R6.htm IDEA: XBRL DOCUMENT v3.3.1.900
Consolidated Statements of Changes in Equity - USD ($)
shares in Millions
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Net Unrealized Gains (Losses) on Investments [Member]
Foreign Currency Translation Losses [Member]
Nonredeemable noncontrolling interests [Member]
Balance at Dec. 31, 2012 $ 31,178,000,000 $ 10,000,000 $ 66,000,000 $ 30,664,000,000 $ 516,000,000 $ (78,000,000) $ 0
Balance (in shares) at Dec. 31, 2012   1,019          
Net earnings attributable to UnitedHealth Group common stockholders 5,625,000,000     5,625,000,000      
Net earnings attributable to nonredeemable noncontrolling interest             0
Net earnings including portion attributable to nonredeemable noncontrolling interest 5,625,000,000            
Other comprehensive income (loss) (1,346,000,000)       (462,000,000) (884,000,000)  
Issuances of common stock, and related tax effects (in shares)   17          
Issuances of common stock, and related tax effects 431,000,000 $ 0 431,000,000        
Share-based compensation, and related tax benefits 406,000,000   406,000,000        
Common stock repurchases (in shares)   (48)          
Common stock repurchases (3,170,000,000) $ 0 (984,000,000) (2,186,000,000)      
Acquisitions of redeemable noncontrolling interests and related tax effects 81,000,000   81,000,000        
Cash dividends paid on common stock (1,056,000,000)     (1,056,000,000)      
Balance at Dec. 31, 2013 32,149,000,000 $ 10,000,000 0 33,047,000,000 54,000,000 (962,000,000) 0
Balance (in shares) at Dec. 31, 2013   988          
Net earnings attributable to UnitedHealth Group common stockholders 5,619,000,000     5,619,000,000      
Net earnings attributable to nonredeemable noncontrolling interest             0
Net earnings including portion attributable to nonredeemable noncontrolling interest 5,619,000,000            
Other comprehensive income (loss) (484,000,000)       169,000,000 (653,000,000)  
Issuances of common stock, and related tax effects (in shares)   15          
Issuances of common stock, and related tax effects 146,000,000 $ 0 146,000,000        
Share-based compensation, and related tax benefits 394,000,000   394,000,000        
Common stock repurchases (in shares)   (49)          
Common stock repurchases (4,008,000,000) $ 0 (540,000,000) (3,468,000,000)      
Cash dividends paid on common stock (1,362,000,000)     (1,362,000,000)      
Balance at Dec. 31, 2014 $ 32,454,000,000 $ 10,000,000 0 33,836,000,000 223,000,000 (1,615,000,000) 0
Balance (in shares) at Dec. 31, 2014 954 954          
Net earnings attributable to UnitedHealth Group common stockholders $ 5,813,000,000     5,813,000,000      
Net earnings attributable to nonredeemable noncontrolling interest             26,000,000
Net earnings including portion attributable to nonredeemable noncontrolling interest 5,839,000,000            
Other comprehensive income (loss) (1,942,000,000)       (167,000,000) (1,775,000,000)  
Issuances of common stock, and related tax effects (in shares)   10          
Issuances of common stock, and related tax effects 127,000,000 $ 0 127,000,000        
Share-based compensation, and related tax benefits 589,000,000   589,000,000        
Common stock repurchases (in shares)   (11)          
Common stock repurchases (1,200,000,000) $ 0 (462,000,000) (738,000,000)      
Cash dividends paid on common stock (1,786,000,000)     (1,786,000,000)      
Redeemable noncontrolling interests fair value and other adjustments (225,000,000)   (225,000,000)        
Acquisition of nonredeemable noncontrolling interest 9,000,000           9,000,000
Distributions to nonredeemable noncontrolling interest (140,000,000)           (140,000,000)
Balance at Dec. 31, 2015 $ 33,725,000,000 $ 10,000,000 $ 29,000,000 $ 37,125,000,000 $ 56,000,000 $ (3,390,000,000) $ (105,000,000)
Balance (in shares) at Dec. 31, 2015 953 953